Back

Cardiac fibrosis: from fibroblast-specific transcriptome to drug discovery prediction

11 May 2024 (13:00 - 13:45)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - pathophysiology and mechanisms 6 Pathophysiology HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Ryeonshi Kang

Institute of Cardiovascular and Metabolic Diseases, Toulouse (France)

6 More presentations in this session

Presentation thumbnail
Saline load induces acute changes in ventricular extracellular volume and mass in an early model of HF
Doctor G. Rossitto (Padova, IT)
Abstract Slides Video
Presentation thumbnail
MYBPC3 genotypes associated with familial hypertrophic cardiomyopathy
Doctor A. Garcia (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Beyond a biomarker, carbohydrate antigen 125 (CA-125) is associated with pathophysiological mechanisms implicated in heart failure
Professor J. Gonzalez Juanatey (Santiago de Compostela, ES)
Abstract Slides Video
Presentation thumbnail
Transplanted liver, altered heart: unveiling the spectrum of cardiomyopathy post-liver transplant in TTR-FAP patients
Doctor J. Santos Fonseca (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Malnutrition indices and prognosis across the BMI range in patients with HFpEF: insights from the PARAGON-HF trial
Doctor H. Lu (Lausanne, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic heart failure - pathophysiology and mechanisms 6

The Event

Event poster

Heart Failure 2024

11 May 2024 13:00 CET
You may be interested in
thumbnail
Congress Presentation
Impact and reversibility of cardiac fibrosis across the spectrum of heart failure
thumbnail
Congress Presentation
Antifibrotic agents
thumbnail
Congress Presentation
Heart failure in the era of single-nuclei and spatial OMICs

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources